Skip to content

What the Blackstone Labs Indictment Means for Payment Service Providers

Last month, six people associated with Blackstone Labs were charged in an indictment to market and sell illegal dietary supplements for use in bodybuilding and weight loss. The indictment is significant because of the size and reach of Blackstone Labs, and because of the way it is alleged to have deceptively labeled products for years. The company website, which processes payment using major credit cards, illustrates how difficult it can be for payment service providers and supplement distributors to identify problematic and potentially dangerous dietary supplements on their own.

According to the Blackstone Labs indictment, the defendants sold hundreds of thousands of illegal products - including ones containing anabolic steroids, selective androgen receptor modulators (SARMs), and other prohormones - in the US and worldwide, marketing them as legal dietary supplements. Anabolic steroids, which are controlled substances, and SARMs, which are investigational new drugs, are prohibited for use in dietary supplements, pursuant to the Federal Food, Drug, and Cosmetic Act. These substances can cause kidney failure, liver damage, and other permanent health problems when used improperly.

The charges against the operators of Blackstone Labs highlight one important takeaway for PSPs and supplement distributors: never take your merchants or manufacturers at their word. Just because products are labeled as dietary supplements does not mean they conform to FDA requirements. There is no guarantee that products marketed as "safe," "natural," or "legal" are, in fact, any of those things. Payment service providers onboarding supplement or pharmaceutical merchants, and distributors adding new third-party supplements to their catalog, must diligently vet the products being sold. Otherwise, they can be on the hook for expensive regulatory fines and even government intervention. To effectively evaluate merchants like these, it helps to stay abreast of recent high-risk trends.

Furthermore, merchants engaged in deceptive practices may be at a higher risk of money laundering to conceal their activities. In the case of Blackstone Labs, principals Phillip Braun and Aaron Singerman were charged with three counts of money laundering each. According to the indictment, the two "established Fight Pharm so that they could shift the sale of drugs and other products from Blackstone to Fight Pharm and to hide such sales from FDA."

The difficulty in identifying problematic dietary supplements may only get worse as this $40 billion industry grows. The FDA reported earlier this year that there are as much as 80,000 unique dietary supplements now available to consumers in the US. That number is likely to grow, especially if the FDA considers allowing CBD to be included in food products after changes to CBD rules in the 2018 Farm Bill.

FDA Commissioner Scott Gottlieb said the administration is launching new efforts to strengthen regulation of dietary supplements. While this may increase safety for consumers, it may also lead to increased scrutiny of dietary supplement merchants and the PSPs that onboard them. Payment service providers wanting to take advantage of the lucrative supplement industry should consider partnering with a monitoring and compliance company such as LegitScript to onboard with confidence. Contact us to learn more about how our expert solutions can help you.

 

David Khalaf is a writing, communications, and marketing professional with specialties in media, investigations, content strategy, and writing instruction. His 20 years of writing, media, and communications work have included two top-tier universities (USC and UCLA), print and digital magazines, consulting firms, and technology companies.

His current work involves content strategy and development at LegitScript, a company that helps the world's leading search engines, payment service providers, and internet platforms and marketplaces do business with legitimate, legally operating entities in more than 80 countries and 15 languages around the world. LegitScript specializes in risk and compliance for highly regulated industries including CBD/cannabis, online gambling, cryptocurrencies, drugs, financial trading, online adult, scams and fraud, and more.

Recent Blog Articles

Synthetic identity fraud

What You Need to Know About Synthetic Identity Fraud

LegitScript noticed an increase in the sale of fraudulent document services, including fake IDs, synthetic identities, and artificial intelligence (AI) passport photo generators. Read further to understand how this trend appears to align with an emergence of more effective methods of stealing and fa...
proposed changes to DSHEA

Proposed Changes to DSHEA Could Impact You — Here’s How

According to the Pew Research Center, many US consumers believe that the current regulatory authority of the Food and Drug Administration (FDA) doesn't adequately protect them. Read further to discover the potential impact of the FDA's proposed changes to the Dietary Supplement Health and Education...

Problematic Product Spotlight: Tainted Royal Honey

Products Claiming to Enhance Sexual Performance Have Experienced a Surge in Popularity No longer relegated to the shelves of gas stations and corner stores, dietary supplements or other products claiming to enhance sexual performance have experienced a surge in popularity within e-commerce marketpla...
LegitScript updates advisory committee policies and seeks to invite new members.

LegitScript Relaunches Its Addiction Treatment Certification Advisory Committee — and Seeks New Members

In an effort to strengthen avenues of communication and identify opportunities for optimizing the client journey, LegitScript is relaunching its Addiction Treatment Certification Advisory Committee. Keep reading to learn how this may impact you. LegitScript Bolsters Collaboration Efforts With Organi...